
Jon E. Angell
Examiner (ID: 3741, Phone: (571)272-0756 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1635, 1637, 1674 |
| Total Applications | 1431 |
| Issued Applications | 721 |
| Pending Applications | 199 |
| Abandoned Applications | 530 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7224788
[patent_doc_number] => 20040072787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Telomerase reverse transcriptase transcriptional regulatory sequences and methods of using'
[patent_app_type] => new
[patent_app_number] => 10/674836
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 25442
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072787.pdf
[firstpage_image] =>[orig_patent_app_number] => 10674836
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/674836 | Telomerase reverse transcriptase transcriptional regulatory sequences and methods of using | Sep 28, 2003 | Abandoned |
Array
(
[id] => 8016973
[patent_doc_number] => 08137989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-20
[patent_title] => 'Method for delivering a cytokine using a colloidal metal'
[patent_app_type] => utility
[patent_app_number] => 10/672144
[patent_app_country] => US
[patent_app_date] => 2003-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10521
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/137/08137989.pdf
[firstpage_image] =>[orig_patent_app_number] => 10672144
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/672144 | Method for delivering a cytokine using a colloidal metal | Sep 25, 2003 | Issued |
Array
(
[id] => 5760694
[patent_doc_number] => 20060211639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/668050
[patent_app_country] => US
[patent_app_date] => 2003-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25738
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10668050
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/668050 | Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer | Sep 21, 2003 | Abandoned |
Array
(
[id] => 7281279
[patent_doc_number] => 20040063656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Screening and therapy for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3)'
[patent_app_type] => new
[patent_app_number] => 10/661740
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17100
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063656.pdf
[firstpage_image] =>[orig_patent_app_number] => 10661740
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/661740 | Screening and therapy for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3) | Sep 11, 2003 | Abandoned |
Array
(
[id] => 5700675
[patent_doc_number] => 20060217360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Tubulysin biosynthesis gene'
[patent_app_type] => utility
[patent_app_number] => 10/526572
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11627
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217360.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526572
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526572 | Tubulysin biosynthesis gene | Sep 2, 2003 | Abandoned |
Array
(
[id] => 133313
[patent_doc_number] => 07696342
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-04-13
[patent_title] => 'Bioinformatically detectable group of novel viral regulatory genes and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/604945
[patent_app_country] => US
[patent_app_date] => 2003-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 26
[patent_no_of_words] => 15263
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/696/07696342.pdf
[firstpage_image] =>[orig_patent_app_number] => 10604945
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/604945 | Bioinformatically detectable group of novel viral regulatory genes and uses thereof | Aug 26, 2003 | Issued |
Array
(
[id] => 7136059
[patent_doc_number] => 20040043956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Antisense modulation of complement component C3 expression'
[patent_app_type] => new
[patent_app_number] => 10/642802
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26650
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043956.pdf
[firstpage_image] =>[orig_patent_app_number] => 10642802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/642802 | Antisense modulation of complement component C3 expression | Aug 17, 2003 | Abandoned |
Array
(
[id] => 7208751
[patent_doc_number] => 20050043524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Modulation of diacylglycerol acyltransferase 2 expression'
[patent_app_type] => utility
[patent_app_number] => 10/643801
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25521
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043524.pdf
[firstpage_image] =>[orig_patent_app_number] => 10643801
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/643801 | Modulation of diacylglycerol acyltransferase 2 expression | Aug 17, 2003 | Issued |
Array
(
[id] => 7250231
[patent_doc_number] => 20050074438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Use of cyclophilin as antioxidant and prevention of cyclosporin a-induced toxicity in cell transplantation by overexpression of cyclophilin'
[patent_app_type] => utility
[patent_app_number] => 10/635264
[patent_app_country] => US
[patent_app_date] => 2003-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 12111
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074438.pdf
[firstpage_image] =>[orig_patent_app_number] => 10635264
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/635264 | Use of cyclophilin as antioxidant and prevention of cyclosporin a-induced toxicity in cell transplantation by overexpression of cyclophilin | Aug 5, 2003 | Abandoned |
Array
(
[id] => 5602911
[patent_doc_number] => 20060293256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Remedy or preventive for kidney disease and method of diagnosing kidney disease'
[patent_app_type] => utility
[patent_app_number] => 10/523689
[patent_app_country] => US
[patent_app_date] => 2003-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18310
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20060293256.pdf
[firstpage_image] =>[orig_patent_app_number] => 10523689
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/523689 | Remedy or preventive for kidney disease and method of diagnosing kidney disease | Aug 4, 2003 | Abandoned |
Array
(
[id] => 7199258
[patent_doc_number] => 20040086487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases'
[patent_app_type] => new
[patent_app_number] => 10/619344
[patent_app_country] => US
[patent_app_date] => 2003-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8393
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086487.pdf
[firstpage_image] =>[orig_patent_app_number] => 10619344
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/619344 | Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases | Jul 13, 2003 | Abandoned |
Array
(
[id] => 7397357
[patent_doc_number] => 20040038895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Inflammation related G-protein coupled receptor'
[patent_app_type] => new
[patent_app_number] => 10/619141
[patent_app_country] => US
[patent_app_date] => 2003-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9828
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038895.pdf
[firstpage_image] =>[orig_patent_app_number] => 10619141
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/619141 | Inflammation related G-protein coupled receptor | Jul 13, 2003 | Abandoned |
Array
(
[id] => 7403669
[patent_doc_number] => 20040023910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas'
[patent_app_type] => new
[patent_app_number] => 10/381644
[patent_app_country] => US
[patent_app_date] => 2003-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18463
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023910.pdf
[firstpage_image] =>[orig_patent_app_number] => 10381644
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/381644 | Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas | Jun 23, 2003 | Abandoned |
Array
(
[id] => 7329839
[patent_doc_number] => 20040254131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels'
[patent_app_type] => new
[patent_app_number] => 10/462039
[patent_app_country] => US
[patent_app_date] => 2003-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7767
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254131.pdf
[firstpage_image] =>[orig_patent_app_number] => 10462039
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/462039 | Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels | Jun 15, 2003 | Abandoned |
Array
(
[id] => 5760029
[patent_doc_number] => 20060210974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Compositions and methods for preventing, treating and diagnosing diabetes'
[patent_app_type] => utility
[patent_app_number] => 10/515892
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24989
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20060210974.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515892
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515892 | Compositions and methods for preventing, treating and diagnosing diabetes | Jun 12, 2003 | Abandoned |
Array
(
[id] => 7362479
[patent_doc_number] => 20040005296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Paramyxovirus vector encoding angiogenesis gene and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/444661
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 22785
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005296.pdf
[firstpage_image] =>[orig_patent_app_number] => 10444661
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/444661 | Paramyxovirus vector encoding angiogenesis gene and use thereof | May 22, 2003 | Abandoned |
Array
(
[id] => 6678177
[patent_doc_number] => 20030228317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Gene BRCC-1 and diagnostic and therapeutic uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/443273
[patent_app_country] => US
[patent_app_date] => 2003-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15963
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228317.pdf
[firstpage_image] =>[orig_patent_app_number] => 10443273
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/443273 | Gene BRCC-1 and diagnostic and therapeutic uses thereof | May 21, 2003 | Abandoned |
Array
(
[id] => 7220042
[patent_doc_number] => 20040072207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Nucleic acids encoding a mammalian raptor polypeptide and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/437421
[patent_app_country] => US
[patent_app_date] => 2003-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 24045
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072207.pdf
[firstpage_image] =>[orig_patent_app_number] => 10437421
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/437421 | Nucleic acids encoding a mammalian raptor polypeptide and uses therefor | May 12, 2003 | Abandoned |
Array
(
[id] => 415384
[patent_doc_number] => 07279568
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-09
[patent_title] => 'Highly efficient eukaryotic expression vector comprising an exogenous transcription regulatory element'
[patent_app_type] => utility
[patent_app_number] => 10/431121
[patent_app_country] => US
[patent_app_date] => 2003-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 8688
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/279/07279568.pdf
[firstpage_image] =>[orig_patent_app_number] => 10431121
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/431121 | Highly efficient eukaryotic expression vector comprising an exogenous transcription regulatory element | May 5, 2003 | Issued |
Array
(
[id] => 5075175
[patent_doc_number] => 20070015150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Novel nucleic acid sequences and proteins of tumors and neoplasias of the thyroid gland'
[patent_app_type] => utility
[patent_app_number] => 10/512809
[patent_app_country] => US
[patent_app_date] => 2003-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26894
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015150.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512809
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512809 | Novel nucleic acid sequences and proteins of tumors and neoplasias of the thyroid gland | May 1, 2003 | Abandoned |